This inventor holds 1 USPTO granted patent. Top assignee: Matrix Laboratories Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Mamidi Srinivas: Innovator in Pharmaceutical Chemistry
Introduction
Mamidi Srinivas is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. His work exemplifies the intersection of science and innovation, leading to advancements in medication formulation.
Latest Patents
Mamidi Srinivas holds a patent for the "Process for the preparation of olmesartan medoxomil." This invention outlines a detailed method for synthesizing Olmesartan medoxomil, a medication used to treat high blood pressure. The process involves several steps, including the condensation of specific chemical compounds and subsequent hydrolysis and deprotection to yield the final product. His patent is a testament to his expertise and dedication to improving pharmaceutical processes. He has 1 patent to his name.
Career Highlights
Srinivas is currently employed at Matrix Laboratories Limited, where he continues to apply his knowledge and skills in pharmaceutical research and development. His role at the company allows him to contribute to the creation of effective medications that can improve patient outcomes. His innovative approach and commitment to excellence have made him a valuable asset in the industry.
Collaborations
Throughout his career, Mamidi Srinivas has collaborated with talented professionals, including Yerramalla Raja Krishna and Madhuresh Kumar Sethi. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking solutions in pharmaceutical chemistry.
Conclusion
Mamidi Srinivas is a distinguished inventor whose work in the preparation of olmesartan medoxomil showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions continue to impact the field positively, and his collaborations with fellow professionals further enhance the potential for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile